Expression and function of junctional adhesion molecule-C in human and experimental arthritis
2007

Role of Junctional Adhesion Molecule-C in Arthritis

Sample size: 10 publication Evidence: moderate

Author Information

Author(s): Gaby Palmer, Nathalie Busso, Michel Aurrand-Lions, Dominique Talabot-Ayer, Véronique Chobaz-Péclat, Claudia Zimmerli, Philippe Hammel, Beat A. Imhof, Cem Gabay

Primary Institution: University Hospital, Geneva, Switzerland

Hypothesis

What is the role of junctional adhesion molecule-C (JAM-C) in the pathogenesis of arthritis?

Conclusion

JAM-C is highly expressed by synovial fibroblasts in rheumatoid arthritis, and treatment with an anti-JAM-C antibody significantly reduced the severity of antigen-induced arthritis and delayed the onset of serum transfer-induced arthritis.

Supporting Evidence

  • JAM-C expression was significantly higher in rheumatoid arthritis compared to osteoarthritis samples.
  • Treatment with anti-JAM-C antibody decreased the severity of antigen-induced arthritis in mice.
  • Neutrophil infiltration into inflamed joints was selectively reduced in anti-JAM-C-treated mice.

Takeaway

JAM-C is a protein that helps cells stick together, and blocking it can make arthritis less severe in mice.

Methodology

The study involved examining JAM-C expression in human and mouse synovial tissues and testing the effects of a monoclonal anti-JAM-C antibody in mouse models of arthritis.

Participant Demographics

Human synovial tissue samples from patients with rheumatoid arthritis and osteoarthritis.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/ar2223

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication